This section is where you can find referenced articles mentioned within our IBD LIVE broadcasts, view the recordings of the program and listen to previews of our music playlist!
Case 1: Double Trouble: Refractory Crohn’s Ileitis c/b Perianal Disease. When to pull the trigger on dual advanced therapies and which ones?
(Presented by Brown University)
Case 2: Steroid-responsive Colitis: Is it IBD?
(Presented by Yale University)
March 12, 2026: Watch Recoding
- IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis
- Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease
- Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn’s Disease: A Descriptive Case Series
- Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases
- AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study
- Systematic Review and Meta-analysis: Faecal Diversion for Management of Perianal Crohn’s Disease
- AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease
- Medline ® Abstract for Reference 56 of ‘Medical management of moderate to severe Crohn disease in adults’
- Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice
- Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula (2022)
- Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
- Risk factors for short bowel syndrome in patients with Crohn’s disease
- Factors affecting poor nutritional status after small bowel resection in patients with Crohn disease
- Systematic Review and Meta-analysis: Faecal Diversion for Management of Perianal Crohn’s Disease
- Long-term outcomes of ‘temporary’ defunctioning in patients with severe perianal Crohn’s disease
- American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection
March 5, 2026: Watch recording
| December 2025 |
|---|
December 6, 2025: Watch Recording
|
| August 2025 |
|---|
| August 21, 2025: Watch Recording |
August 14, 2025: Watch Recording
|
| August 7, 2025: Watch Recording |
| FEBRUARY 2025 |
|---|
February 27, 2024: Watch Recording
|
| February 20, 2025: Watch Recording |
| February 13, 2025: Watch Recording |
February 6, 2025: Watch Recording
|
